Cargando…
Neutralization of Clostridium difficile toxin B with V(H)H-Fc fusions targeting the delivery and CROPs domains
An increasing number of antibody-based therapies are being considered for controlling bacterial infections, including Clostridium difficile by targeting toxins A and B. In an effort to develop novel C. difficile immunotherapeutics, we previously isolated several single-domain antibodies (V(H)Hs) cap...
Autores principales: | Hussack, Greg, Ryan, Shannon, van Faassen, Henk, Rossotti, Martin, MacKenzie, C. Roger, Tanha, Jamshid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291252/ https://www.ncbi.nlm.nih.gov/pubmed/30540857 http://dx.doi.org/10.1371/journal.pone.0208978 |
Ejemplares similares
-
Toxin-Specific Antibodies for the Treatment of Clostridium difficile: Current Status and Future Perspectives (†)
por: Hussack, Greg, et al.
Publicado: (2010) -
Structure-guided design of a potent Clostridioides difficile toxin A inhibitor
por: Hussack, Greg, et al.
Publicado: (2023) -
Corrigendum: Structure-guided design of a potent Clostridioides difficile toxin A inhibitor
por: Hussack, Greg, et al.
Publicado: (2023) -
An update on antibody-based immunotherapies for Clostridium difficile infection
por: Hussack, Greg, et al.
Publicado: (2016) -
Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease
por: Kandalaft, Hiba, et al.
Publicado: (2015)